• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Advancing precision-based antimicrobial dosing in critically ill patients.

作者信息

Cotta Menino O, Lipman Jeffrey, De Waele Jan

机构信息

UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.

Department of Intensive Care Medicine, Royal Brisbane and Women's hospital, Butterfield Street, Herston, Brisbane, QLD, Australia.

出版信息

Intensive Care Med. 2023 Mar;49(3):324-326. doi: 10.1007/s00134-022-06969-7. Epub 2023 Jan 25.

DOI:10.1007/s00134-022-06969-7
PMID:36695835
Abstract
摘要

相似文献

1
Advancing precision-based antimicrobial dosing in critically ill patients.推进危重症患者基于精准医学的抗菌药物给药方案
Intensive Care Med. 2023 Mar;49(3):324-326. doi: 10.1007/s00134-022-06969-7. Epub 2023 Jan 25.
2
Adequate Antimicrobial Dosing in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation: Where to Go from Here?接受体外膜肺氧合治疗的重症患者的抗菌药物合理给药：下一步何去何从？
Am J Respir Crit Care Med. 2023 Mar 15;207(6):649-651. doi: 10.1164/rccm.202210-2000ED.
3
What's new in antimicrobial use and resistance in critically ill patients?危重症患者抗菌药物使用及耐药性方面有哪些新情况？
Intensive Care Med. 2014 Mar;40(3):422-6. doi: 10.1007/s00134-013-3190-7. Epub 2013 Dec 18.
4
What can be expected from antimicrobial de-escalation in the critically ill?对于危重症患者的抗菌药物降阶梯治疗，我们可以期待什么？
Intensive Care Med. 2014 Jan;40(1):92-5. doi: 10.1007/s00134-013-3154-y. Epub 2013 Nov 19.
5
Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients.专家临床药理学建议可能使新兴候选药物的抗菌药物治疗药物监测（TDM）计划在为危重症患者制定治疗方案方面更具临床实用性。
Crit Care. 2022 Jun 14;26(1):178. doi: 10.1186/s13054-022-04050-9.
6
Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy.重症患者哌拉西林给药个体化：优化抗菌治疗的给药软件
Antimicrob Agents Chemother. 2014 Jul;58(7):4094-102. doi: 10.1128/AAC.02664-14. Epub 2014 May 5.
7
Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software.帮助机器帮助患者的机器：使用剂量软件优化接受体外膜氧合和肾脏替代治疗的患者的抗菌药物剂量。
Intensive Care Med. 2022 Oct;48(10):1338-1351. doi: 10.1007/s00134-022-06847-2. Epub 2022 Aug 23.
8
Personalized antibiotic dosing for the critically ill.危重症患者的个性化抗生素给药
Intensive Care Med. 2019 May;45(5):715-718. doi: 10.1007/s00134-019-05522-3. Epub 2019 Jan 14.
9
An antimicrobial stewardship program improves antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients.抗菌药物管理计划可改善重症患者按培养部位进行的抗菌治疗以及抗菌药物处方质量。
Crit Care. 2012 Nov 5;16(6):R216. doi: 10.1186/cc11854.
10
Comment: once-daily aminoglycoside dosing in critically ill patients.
Ann Pharmacother. 1998 Oct;32(10):1109-10. doi: 10.1345/aph.17243b.

引用本文的文献

1
Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis.使用贝叶斯给药软件在患有脓毒症的重症儿童和成人中实现治疗性抗生素暴露。
Intensive Care Med. 2024 Apr;50(4):539-547. doi: 10.1007/s00134-024-07353-3. Epub 2024 Mar 13.
2
Exploring the Impact of Model-Informed Precision Dosing on Procalcitonin Concentrations in Critically Ill Patients: A Secondary Analysis of the DOLPHIN Trial.探索模型指导的精准给药对重症患者降钙素原浓度的影响：海豚试验的二次分析
Pharmaceutics. 2024 Feb 14;16(2):270. doi: 10.3390/pharmaceutics16020270.
3
Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting.
朝向哌拉西林的模型指导下精准给药：以贝叶斯预测为重点，对危重症成年患者的药代动力学模型进行多中心系统外部评估。
Intensive Care Med. 2023 Aug;49(8):966-976. doi: 10.1007/s00134-023-07154-0. Epub 2023 Jul 13.
4
The Current Status and Future Perspectives of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients.β-内酰胺类药物在危重症患者中治疗药物监测的现状与未来展望
Antibiotics (Basel). 2023 Mar 30;12(4):681. doi: 10.3390/antibiotics12040681.
5
Optimization of Therapy and the Risk of Probiotic Use during Antibiotherapy in Septic Critically Ill Patients: A Narrative Review.优化治疗策略与益生菌在脓毒症危重症患者抗生素治疗期间应用的风险：一项叙述性综述。
Medicina (Kaunas). 2023 Feb 28;59(3):478. doi: 10.3390/medicina59030478.
6
Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients-A Narrative Review.重症患者β-内酰胺类抗生素治疗药物监测的最新进展——一项叙述性综述
Antibiotics (Basel). 2023 Mar 13;12(3):568. doi: 10.3390/antibiotics12030568.
7
Individualised dosing of antibiotics in ICU patients: timing, target and model selection matter. Author's reply.重症监护病房患者抗生素的个体化给药：时机、目标和模型选择很重要。作者回复。
Intensive Care Med. 2023 Apr;49(4):477-478. doi: 10.1007/s00134-023-07002-1. Epub 2023 Feb 17.